BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11318976)

  • 1. Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection.
    Delladetsima JK; Makris F; Psichogiou M; Kostakis A; Hatzakis A; Boletis JN
    Liver; 2001 Apr; 21(2):81-8. PubMed ID: 11318976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholestatic syndromes in renal transplant recipients with HCV infection.
    Boletis JN; Delladetsima JK; Makris F; Theodoropoulou H; Vgenopoulou S; Kostakis A; Hatzakis A
    Transpl Int; 2000; 13 Suppl 1():S375-9. PubMed ID: 11112036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications.
    Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL
    Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholestatic hepatitis C in liver allografts.
    Taga SA; Washington MK; Terrault N; Wright TL; Somberg KA; Ferrell LD
    Liver Transpl Surg; 1998 Jul; 4(4):304-10. PubMed ID: 9649645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients.
    Muñoz De Bustillo E; Ibarrola C; Colina F; Castellano G; Fuertes A; Andrés A; Aguado JM; Rodicio JL; Morales JM
    J Am Soc Nephrol; 1998 Jun; 9(6):1109-13. PubMed ID: 9621297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study.
    Delladetsima I; Psichogiou M; Sypsa V; Psimenou E; Kostakis A; Hatzakis A; Boletis JN
    Am J Kidney Dis; 2006 Feb; 47(2):309-16. PubMed ID: 16431260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
    Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time of acquisition of HCV infection in renal transplant recipients: a major prognostic factor for disease progression.
    Delladetsima I; Psichogiou M; Sypsa V; Sakellariou S; Hatzakis A; N Boletis J
    Clin Transplant; 2013; 27(1):72-9. PubMed ID: 22994949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study.
    Mahmoud IM; Elhabashi AF; Elsawy E; El-Husseini AA; Sheha GE; Sobh MA
    Am J Kidney Dis; 2004 Jan; 43(1):131-9. PubMed ID: 14712436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience of fibrosing cholestatic hepatitis with hepatitis C virus in kidney transplant recipients.
    Siddiqui AR; Abbas Z; Luck NH; Hassan SM; Aziz T; Mubarak M; Naqvi SA; Rizvi SA
    Transplant Proc; 2012 Apr; 44(3):721-4. PubMed ID: 22483477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
    Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
    Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage.
    Giannini E; Botta F; Fasoli A; Romagnoli P; Mastracci L; Ceppa P; Comino I; Pasini A; Risso D; Testa R
    Dig Dis Sci; 2001 Mar; 46(3):524-9. PubMed ID: 11318526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features of rapidly progressive hepatitis C virus infection in HCV antibody negative renal transplant recipients.
    Ok E; Unsal A; Celik A; Zeytinoğlu A; Ersöz G; Tokat Y; Erensoy S; Akarca US; Basçi A; Yüce G
    Nephrol Dial Transplant; 1998 Dec; 13(12):3103-7. PubMed ID: 9870473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection.
    Lim HL; Lau GK; Davis GL; Dolson DJ; Lau JY
    Gastroenterology; 1994 Jan; 106(1):248-51. PubMed ID: 8276189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous interferon during the anhepatic phase of liver retransplantation and prevention of recurrence of cholestatic hepatitis C virus.
    Kwo PY; Saxena R; Cummings OW; Tector AJ
    Liver Transpl; 2007 Dec; 13(12):1710-3. PubMed ID: 18044743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients].
    Rostaing L; Izopet J; Arnaud C; Rumeau JL; Duffaut M; Cisterne JM; Durand D
    Nephrologie; 1999; 20(3):165-70. PubMed ID: 10418007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
    Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
    Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.